IGF1 and prostate carcinoma: Similar estimates have been observed utilising MR analyses [19, 20], with the exception that a 5 nmol/L genetically predicted higher IGF-I concentration has been associated with a 34% higher risk of prostate cancer when using a cis-SNP, although CIs were wide [21].